Article
Loss of EIF4G2 Mediates Aggressiveness in Distinct Human Endometrial Cancer Subpopulations…
medRxiv · 2023 · Meril, S.; Muhlbauer Avni, M.; Lior, C.; Bhalsen, M.; Olender, T.; Savidor, A.; Krausz, J.; Belhanes Peled, H.; Birisi, H.; David, N.; Bialik, S.; Scherz-Shouval, R.; Ben David, Y.; Kimchi, A.
Key facts
| Title | Loss of EIF4G2 Mediates Aggressiveness in Distinct Human Endometrial Cancer Subpopulations with Poorer Survival Outcome in Patients |
|---|---|
| First author | Meril, S.; Muhlbauer Avni, M.; Lior, C.; Bhalsen, M.; Olender, T.; Savidor, A.; Krausz, J.; Belhanes Peled, H.; Birisi, H.; David, N.; Bialik, S.; Scherz-Shouval, R.; Ben David, Y.; Kimchi, A. |
| Journal | medRxiv |
| Published | Sep 17, 2023 |
| DOI | 10.1101/2023.09.14.557672 |
| Devices mentioned | K852441, K854177, K854178, K854179, K854180, K854181, K854182, K854183, K854184, K854185, K854186, K854187 and 1 more |
| Product codes mentioned | CEK, MVU |
At a glance
- 10–99 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1